Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation. (15th March 2021)

• Record Type: Journal Article
• Authors: Rittenhouse, Katelyn J.; Mwape, Humphrey; Nelson, Julie A.E.; Mwale, John; Chipili, Gabriel; Price, Joan T.; Hudgens, Michael; Stringer, Elizabeth M.; De Paris, Kristina; Vwalika, Bellington; Stringer, Jeffrey S.A.
• Is Part Of: AIDS. Volume 35:Number 4(2021)
• Page Start: 555
• Page End: 565
• Publication Date: 2021-03-15
• Subjects: cytokines -- HIV -- preterm birth -- spontaneous preterm birth -- vaginal inflammation -- Zambia; AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome; AIDS (Disease); Periodicals; Periodicals; 616.9792005
• DOI: 10.1097/QAD.0000000000002808
• Languages: English
• ISSNs: 0269-9370

Abstract

Abstract : Supplemental Digital Content is available in the text Abstract : Objective: To assess plasma and vaginal inflammation in three antenatal groups (HIV-uninfected women, HIV-infected women entering care on preconceptional ART, and HIV-infected women not on preconceptional ART) and whether these measures are associated with spontaneous preterm birth (sPTB). Design: Case--control study nested within a pregnancy cohort in Lusaka, Zambia. Methods: We analyzed 11 pro-inflammatory and two anti-inflammatory markers in 207 women with paired plasma and vaginal specimens collected between 16 and 20 gestational weeks. Among 51 HIV-infected women, we repeated the assays in 24–34-week samples. We used confirmatory factor analysis to create inflammation scores and compared them among the three groups. Results: At baseline, HIV-infected women not on ART had higher vaginal pro-inflammatory scores than HIV-uninfected women [mean 0.37 (95% CI −0.06 to 0.80) vs. −0.02 (−0.32 to 0.27), P = 0.02]. In repeat testing, women not on preconceptional ART had an increase in vaginal inflammation between the baseline and 24–34-week visits compared with those continuing preconceptional ART [mean 0.62 (95% CI −0.80 to 4.20) vs. −0.07 (−2.78 to 2.11), P = 0.04]. In multivariate analyses, baseline vaginal inflammation predicted sPTB (aOR 1.5; 95% CI 1.0–2.3; P = 0.02). Plasma inflammation did not differ by HIV or ART exposure and was not associated with sPTB. Conclusion: Women not receiving ART at entry into pregnancy care had more vaginal inflammation than women entering on treatment. They also experienced an increase in vaginal inflammation between the two sampling timepoints, possibly as a consequence of ART initiation. Vaginal (but not systemic) inflammation was associated with sPTB and offers a potential mechanistic insight into this important adverse birth outcome.